These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2982643)

  • 81. Catalytic mechanism of angiotensin-converting enzyme and effects of the chloride ion.
    Zhang C; Wu S; Xu D
    J Phys Chem B; 2013 Jun; 117(22):6635-45. PubMed ID: 23672666
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Assessment of kininases in rheumatic diseases and the effect of therapeutic agents.
    Sheikh IA; Kaplan AP
    Arthritis Rheum; 1987 Feb; 30(2):138-45. PubMed ID: 3030335
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hydrolysis of bradykinin by angiotensin-converting enzyme.
    Dorer FE; Kahn JR; Lentz KE; Levine M; Skeggs LT
    Circ Res; 1974 Jun; 34(6):824-7. PubMed ID: 4364999
    [No Abstract]   [Full Text] [Related]  

  • 84. Conversion of atriopeptin II to atriopeptin I by atrial dipeptidyl carboxy hydrolase.
    Harris RB; Wilson IB
    Peptides; 1985; 6(3):393-6. PubMed ID: 2999723
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Purification and characterization of the angiotensin converting enzyme secretase.
    Connolly C; Oppong SY; Turner AJ; Hooper NM
    Biochem Soc Trans; 1995 Nov; 23(4):551S. PubMed ID: 8654736
    [No Abstract]   [Full Text] [Related]  

  • 86. [Effects of des-Arg9-bradykinin and its kininase II-hydrolyzing products on rat polymorphonuclear leucocyte emigration in vitro].
    Inokuchi J; Nagamatsu A; Taniguchi Y; Toda A
    Yakugaku Zasshi; 1984 Jun; 104(6):695-8. PubMed ID: 6094784
    [No Abstract]   [Full Text] [Related]  

  • 87. Presence and comparison of angiotensin converting enzyme in commercial cell culture sera.
    Bramucci M; Miano A; Quassinti L; Maccari E; Murri O; Amici D
    Biochem Mol Biol Int; 1999 Jan; 47(1):107-15. PubMed ID: 10092950
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Kininase of the Latrodectus tredecimguttatus venom: a study of its enzyme substrate specificity.
    Akhunov AA; Makevnina LG; Golubenko Z; Paskhina TS
    Immunopharmacology; 1996 May; 32(1-3):160-2. PubMed ID: 8796297
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Human lung post-proline endopeptidase: purification and action on vasoactive peptides.
    Zolfaghari R; Baker CR; Canizaro PC; Feola M; Amirgholami A; Bĕhal FJ
    Enzyme; 1986; 36(3):165-78. PubMed ID: 3542526
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Interactions among challenges of hydromineral balance, angiotensin-converting enzyme, and cystine aminopeptidase.
    Silveira PF; Irazusta J; Gil J; Agirregoitia N; Casis L
    Peptides; 2001 Dec; 22(12):2137-44. PubMed ID: 11786201
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Degradation of bradykinin by peritoneal and alveolar macrophages of the guinea pig.
    Vietinghoff G; Paegelow I
    Peptides; 2000 Aug; 21(8):1249-55. PubMed ID: 11035212
    [TBL] [Abstract][Full Text] [Related]  

  • 92. In vitro study on the effects of bradykinin potentiating factor and angiotensin II analogue on degradation and conversion of angiotensin I and II in plasma.
    Ogihara T; Yamamoto T; Doi K; Kumahara Y; Kimura T
    Clin Chim Acta; 1974 May; 52(3):287-92. PubMed ID: 4365353
    [No Abstract]   [Full Text] [Related]  

  • 93. Increase in activity for the C-terminal Pro-X bond by site-directed mutagenesis of Gly137 to Ala in carboxypeptidase Z.
    Ratanakhanokchai K; Lee BR; Kobayashi Y; Takeuchi M
    Biosci Biotechnol Biochem; 1996 Mar; 60(3):496-7. PubMed ID: 8901112
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Angiotensin I converting enzyme.
    Erdös EG
    Circ Res; 1975 Feb; 36(2):247-55. PubMed ID: 234806
    [No Abstract]   [Full Text] [Related]  

  • 95. Inhibition of the angiotensin I converting enzyme of the lung by a peptide fragment of bradykinin.
    Oshima G; Erdös EG
    Experientia; 1974 Jul; 30(7):733-4. PubMed ID: 4367995
    [No Abstract]   [Full Text] [Related]  

  • 96. The degradation of bradykinin (BK) and of des-Arg9-BK in plasma.
    Marceau F; Gendreau M; Barabé J; St-Pierre S; Regoli D
    Can J Physiol Pharmacol; 1981 Feb; 59(2):131-8. PubMed ID: 7225939
    [No Abstract]   [Full Text] [Related]  

  • 97. Cleavage of the Arg1-Pro2 bond of bradykinin by a human lung peptidase: isolation, characterization, and inhibition by several beta-lactam antibiotics.
    Sidorowicz W; Szechiński J; Canizaro PC; Bĕhal FJ
    Proc Soc Exp Biol Med; 1984 Apr; 175(4):503-9. PubMed ID: 6709646
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Kinetic study of angiotensin converting enzyme activity by capillary electrophoresis after in-line reaction at the capillary inlet.
    Van Dyck S; Vissers S; Van Schepdael A; Hoogmartens J
    J Chromatogr A; 2003 Feb; 986(2):303-11. PubMed ID: 12597637
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Isolation of renal membranes that contain kallikrein, angiotensin I-converting enzyme (kininase II) and angiotensinase in the rat.
    Ward PE; Erdös EG; Gedney CD; Dowben RM; Reynolds RC
    Clin Sci Mol Med Suppl; 1976 Dec; 3():267s-270s. PubMed ID: 192512
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Comparison of hydrolysis of atriopeptin II stand-in substrate by atrial dipeptidyl carboxyhydrolase and angiotension I-converting enzyme.
    Harris RB; Wilson IB
    Int J Pept Protein Res; 1985 Jul; 26(1):78-82. PubMed ID: 2997058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.